Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
about
Exercise for cancer cachexia in adultsExercise for cancer cachexia in adultsMuscle dysfunction in cancer patientsThe evaluation of body composition: a useful tool for clinical practiceCancer cachexia: impact, mechanisms and emerging treatmentsAssociation of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective reviewGhrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.Lean body mass: the development and validation of prediction equations in healthy adultsInflammation based regulation of cancer cachexiaPrevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres.Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life.Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal CancersProgressive resistance training and cancer testis (PROTRACT) - efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial.Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer.The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.Sarcopenia as a prognostic biomarker of advanced urothelial carcinomaA decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab.Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients.Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal CancerImaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome.Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinomaBody Composition and Anti-Neoplastic Treatment in Adult and Older Subjects - A Systematic Review.Measuring body composition using the bioelectrical impedance method can predict the outcomes of gemcitabine-based chemotherapy in patients with pancreatobiliary tract cancer.Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinibMaking the most of the imaging we have: using head MRI to estimate body composition.Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients.Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens.Incorporating biomarkers into cancer and aging research.Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.Skeletal Muscle Changes After Elective Colorectal Cancer Resection: A Longitudinal Study.Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study.A pilot study of temsirolimus and body composition.Prognostic significance of sarcopenia in upper tract urothelial carcinoma patients treated with radical nephroureterectomy.Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy.Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease.Variation of adverse drug reaction profile of platinum-based chemotherapy with body mass index in patients with solid tumors: an observational study.Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study.Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer.Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.
P2860
Q24187827-8E62B237-584A-43D6-B6FA-556F6EE5B034Q24197733-EFDE2606-018C-4AB2-9212-32CE5625C273Q26822365-7B6ACABA-AA08-4F2F-A981-32E4D0A109DFQ26825173-C8439FC6-F165-4264-9956-B755387EDF5EQ28384479-0B11E5D1-90A4-4D0C-9ACF-39160FFD9369Q28545175-E969DFAD-5095-4DC9-A550-D86FEDB76F4BQ30384810-EE7B38B4-B0A5-4C15-8390-65D86E52447AQ31150922-C72A8C14-87B4-40CC-8F21-ECC4E9231BE6Q33615916-58F9BD6A-0D0E-40E4-8C2F-8B4286B089AFQ33747381-57E39C2C-8D06-4824-84E8-C92A0CD446E4Q33841708-26569CB2-DF51-4C0A-9328-8C1DB1065140Q33854959-A9F31F5C-A8FB-455B-A12F-B755C7BFE492Q33977589-7479ABCA-DD6D-489C-B79A-DD6771EB3073Q34228955-A6ECC78B-AF65-41D4-9802-EECBF2E02D08Q34369105-614C2132-C718-4306-9453-E5F34A2F3A55Q34672667-62FB714F-8E06-43B7-A37B-C6B8EAC50B45Q35001652-54F825B4-FAFE-478B-A414-DA294B6FB0C4Q35195086-EE1C4D3A-1B97-4AD9-8DEA-FD7F2F0501BEQ35617684-073B3E09-5C61-41E9-9CC0-ABAEFBC2D6B8Q35662253-555E935B-C065-41BA-B621-71606F0C1E19Q35902270-BB6C745C-2549-4D0B-98C3-282206C5C4C1Q35949518-86118265-E720-4875-8BB6-C9667E0A5C16Q36154581-4861DAB8-1C0B-4527-8005-757663AC8BF1Q36336092-5F8CD22B-79B5-449B-AE21-8BD8C81E09DCQ36349363-9E2A49F1-2B3A-4276-B3FE-7B525B76FBB1Q36636102-24C7F791-545F-42CF-A181-E2987E1BE024Q36746780-F902BB3D-C901-4CD9-AC0E-ED8FAB4842D0Q36797250-23589E22-E035-4B57-B823-30D985C73F63Q36925138-C66B2AD1-E97E-4171-923A-8CF3DEC57E3CQ37030118-8BB74AAF-D824-479B-A78C-6B1444243365Q37053402-F64B5F5B-AE8B-4901-B125-8BC5D9BFEA29Q37106252-66A35B02-A43D-4057-8C00-36BE50E74D29Q37313713-68171A47-2D85-4827-B011-2A1EA265C332Q37321124-86377B83-52B1-4EC7-BF34-A1255AAC0C54Q37456742-A26D897B-EF62-4077-9416-3CCFD5393833Q37620338-7A3DCCE3-7E1C-4055-BBD1-007E0D9BCEF3Q37703566-7FE4FE46-47F1-4780-AD67-F2A60931F0ADQ37708767-85A2FB02-8ECE-4F6A-8A89-39B24102B89FQ37717197-99CC110C-6520-4792-87D8-DA5E8AD462B4Q37963505-820648C9-AAF2-4B03-8BC1-342CCD8320BE
P2860
Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Body composition as an indepen ...... l-based chemotherapy toxicity.
@en
Body composition as an indepen ...... l-based chemotherapy toxicity.
@nl
type
label
Body composition as an indepen ...... l-based chemotherapy toxicity.
@en
Body composition as an indepen ...... l-based chemotherapy toxicity.
@nl
prefLabel
Body composition as an indepen ...... l-based chemotherapy toxicity.
@en
Body composition as an indepen ...... l-based chemotherapy toxicity.
@nl
P2093
P1476
Body composition as an indepen ...... l-based chemotherapy toxicity.
@en
P2093
Andrew G Scarfe
Carla M M Prado
Charles A Butts
Karen E Mulder
Linda J McCargar
Marina Mourtzakis
Michael B Sawyer
Tony Reiman
P304
P356
10.1158/1078-0432.CCR-06-3067
P407
P577
2007-06-01T00:00:00Z